ACTRN12615000173594已完成2 期
A proof-of-concept, placebo-controlled clinical trial to compare the efficacy of different formulations of omega-3 essential fatty acid supplements for treating contact lens discomfort
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Existing contact lens wearers (for at least 6 months), with symptoms of contact lens discomfort (CLDEQ-8 score of at least 13).
排除标准
- •Co-morbid ocular pathology (e.g., ocular infection, intra-ocular inflammation)
- •Uncontrolled systemic disease
- •Known or suspected allergy to fish/seafood, nuts, oil or gelatin
- •Current medication with oral omega-3 supplements
- •A systemic medical condition where omega-3 supplements are contraindicated (e.g., bleeding disorders, diabetes, atrial fibrillation, familial immunocompromise, adenomatous polyposis, liver disease)
研究者
相似试验
已完成
2 期
Omega-3 supplements for treating dry eye diseaseACTRN12614001019695The University of Melbourne60
已完成
2 期
Omega-3 supplements for improving peripheral nerve health in type-1 diabetesACTRN12618000705280The University of Melbourne43
进行中（未招募）
1 期
A Study to Test the Effects of Exenatide Once Weekly on Cardiovascular Outcomes in Patients with Type 2 DiabetesType 2 diabetes mellitusMedDRA version: 20.0Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2010-021069-63-SKAmylin Pharmaceuticals, LLC14,000
已完成
3 期
A randomized, placebo, controlled clinical trial to evaluate cardiovascular outcomes after treatment with Exenatide Once Weekly in patients with type 2 diabetes mellitusnon-insulin dependent diabetesType 2 diabetes mellitus10018424NL-OMON41366Amylin Pharmaceuticals, LLC204
进行中（未招募）
1 期
A Study to Test the Effects of Exenatide Once Weekly on Cardiovascular Outcomes in Patients with Type 2 DiabetesType 2 diabetes mellitusMedDRA version: 17.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2010-021069-63-BEAmylin Pharmaceuticals, LLC14,000